Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04925479
Title	Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Novartis Pharmaceuticals
Indications	chronic myeloid leukemia
Therapies	Asciminib
Age Groups:	adult \| child
Covered Countries	USA \| TUR \| POL \| NLD \| ITA \| HUN \| GRC \| FRA \| DEU